Breaking News

Friday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
DBVT

DBV Technologies

$34.65

0.11 (0.32%)

10:35
02/17/17
02/17
10:35
02/17/17
10:35
Upgrade
DBV Technologies rating change  »

DBV Technologies upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

AIMT

Aimmune

$20.08

0.05 (0.25%)

, DBVT

DBV Technologies

$34.65

0.11 (0.32%)

06:20
02/17/17
02/17
06:20
02/17/17
06:20
Recommendations
Aimmune, DBV Technologies analyst commentary  »

Piper sees Aimmune trial…

AIMT

Aimmune

$20.08

0.05 (0.25%)

DBVT

DBV Technologies

$34.65

0.11 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

Over a month ago
ACRX

AcelRx

$2.70

0.05 (1.89%)

, ADAP

Adaptimmune

$4.22

0.06 (1.44%)

04:55
01/12/17
01/12
04:55
01/12/17
04:55
Conference/Events
Trout Group to hold a conference »

Trout Group Annual 1:1…

ACRX

AcelRx

$2.70

0.05 (1.89%)

ADAP

Adaptimmune

$4.22

0.06 (1.44%)

AMRN

Amarin

$2.99

-0.04 (-1.32%)

ARNA

Arena Pharmaceuticals

$1.41

-0.03 (-2.08%)

CASC

Cascadian Therapeutics

$4.64

-0.13 (-2.73%)

DBVT

DBV Technologies

$34.96

-0.29 (-0.82%)

ENZ

Enzo Biochem

GWPH

GW Pharmaceuticals

$119.06

-4.75 (-3.84%)

GERN

Geron

$2.10

-0.1 (-4.55%)

XLRN

Acceleron

$25.70

-1.01 (-3.78%)

MIRN

Mirna Therapeutics

$1.97

-0.0393 (-1.96%)

RDHL

RedHill Biopharma

$10.55

0.1 (0.96%)

RPRX

Repros Therapeutics

$1.39

-0.01 (-0.71%)

RIGL

Rigel Pharmaceuticals

$2.35

-0.08 (-3.29%)

VVUS

VIVUS

$1.21

-0.03 (-2.42%)

CUR

Neuralstem

$4.65

-1.41 (-23.27%)

NVLS

Nivalis Therapeutics

$2.27

-0.04 (-1.73%)

OMED

OncoMed

$8.15

-0.6 (-6.86%)

PIRS

Pieris Pharmaceuticals

$1.87

0.05 (2.75%)

RETA

Reata Pharmaceuticals

$22.60

-0.8 (-3.42%)

RARE

Ultragenyx

$71.10

-2.75 (-3.72%)

STML

Stemline

$13.45

-0.5 (-3.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Jan

  • 01

    Feb

ACRX

AcelRx

$2.65

0.1 (3.92%)

, ADAP

Adaptimmune

$4.16

0.09 (2.21%)

04:55
01/11/17
01/11
04:55
01/11/17
04:55
Conference/Events
Trout Group to hold a conference »

Trout Group Annual 1:1…

ACRX

AcelRx

$2.65

0.1 (3.92%)

ADAP

Adaptimmune

$4.16

0.09 (2.21%)

AMRN

Amarin

$3.03

-0.02 (-0.66%)

ARNA

Arena Pharmaceuticals

$1.44

-0.04 (-2.70%)

CASC

Cascadian Therapeutics

$4.77

-0.2 (-4.02%)

DBVT

DBV Technologies

$35.25

0.16 (0.46%)

ENZ

Enzo Biochem

$7.19

0.14 (1.99%)

GWPH

GW Pharmaceuticals

$123.81

3.79 (3.16%)

GERN

Geron

$2.20

-0.01 (-0.45%)

XLRN

Acceleron

$26.71

0.15 (0.56%)

MIRN

Mirna Therapeutics

$2.01

0.05 (2.55%)

RDHL

RedHill Biopharma

$10.45

-0.12 (-1.14%)

RPRX

Repros Therapeutics

$1.40

0.02 (1.45%)

RIGL

Rigel Pharmaceuticals

$2.43

0.03 (1.25%)

VVUS

VIVUS

$1.24

-0.03 (-2.36%)

CUR

Neuralstem

$6.06

2.25 (59.06%)

NVLS

Nivalis Therapeutics

$2.31

0.04 (1.76%)

OMED

OncoMed

$8.75

0.05 (0.57%)

PIRS

Pieris Pharmaceuticals

$1.82

-0.04 (-2.15%)

RETA

Reata Pharmaceuticals

$23.40

-1.95 (-7.69%)

RARE

Ultragenyx

$73.85

-0.92 (-1.23%)

STML

Stemline

$13.95

0.75 (5.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jan

  • 11

    Jan

  • 01

    Feb

ACRX

AcelRx

$2.55

-0.05 (-1.92%)

, ADAP

Adaptimmune

04:55
01/10/17
01/10
04:55
01/10/17
04:55
Conference/Events
Trout Group to hold a conference »

Trout Group Annual 1:1…

ACRX

AcelRx

$2.55

-0.05 (-1.92%)

ADAP

Adaptimmune

AMRN

Amarin

$3.05

0.05 (1.67%)

ARNA

Arena Pharmaceuticals

$1.48

-0.03 (-1.99%)

CASC

Cascadian Therapeutics

$4.97

0.125 (2.58%)

DBVT

DBV Technologies

$35.09

0.02 (0.06%)

ENZ

Enzo Biochem

$7.05

-0.1 (-1.40%)

GWPH

GW Pharmaceuticals

$120.02

1.66 (1.40%)

GERN

Geron

$2.21

-0.1 (-4.33%)

XLRN

Acceleron

$26.56

0.31 (1.18%)

MIRN

Mirna Therapeutics

$1.96

-0.03 (-1.51%)

RDHL

RedHill Biopharma

$10.57

-0.31 (-2.85%)

RPRX

Repros Therapeutics

$1.38

0.02 (1.47%)

RIGL

Rigel Pharmaceuticals

$2.40

0.01 (0.42%)

VVUS

VIVUS

$1.27

0.02 (1.60%)

CUR

Neuralstem

$3.81

3.5021 (1,137.41%)

NVLS

Nivalis Therapeutics

$2.27

0.03 (1.34%)

OMED

OncoMed

$8.70

0.02 (0.23%)

PIRS

Pieris Pharmaceuticals

$1.86

-0.02 (-1.06%)

RETA

Reata Pharmaceuticals

$25.35

1.43 (5.98%)

RARE

Ultragenyx

$74.77

-2.2 (-2.86%)

STML

Stemline

$13.20

0.3 (2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jan

  • 10

    Jan

  • 11

    Jan

  • 01

    Feb

ACRX

AcelRx

$2.60

-0.05 (-1.89%)

, ADAP

Adaptimmune

$4.07

-0.06 (-1.45%)

08:50
01/09/17
01/09
08:50
01/09/17
08:50
Conference/Events
Trout Group to hold a conference »

Trout Group Annual 1:1…

ACRX

AcelRx

$2.60

-0.05 (-1.89%)

ADAP

Adaptimmune

$4.07

-0.06 (-1.45%)

AMRN

Amarin

$3.00

-0.06 (-1.96%)

ARNA

Arena Pharmaceuticals

CASC

Cascadian Therapeutics

$4.85

-0.055 (-1.12%)

DBVT

DBV Technologies

$35.07

0.08 (0.23%)

ENZ

Enzo Biochem

$7.15

0.08 (1.13%)

GWPH

GW Pharmaceuticals

$118.36

0.62 (0.53%)

GERN

Geron

$2.31

0.11 (5.00%)

XLRN

Acceleron

$26.25

-0.79 (-2.92%)

MIRN

Mirna Therapeutics

$1.99

0.039 (2.00%)

RDHL

RedHill Biopharma

$10.88

0.29 (2.74%)

RPRX

Repros Therapeutics

RIGL

Rigel Pharmaceuticals

$2.39

-0.07 (-2.85%)

VVUS

VIVUS

$1.25

-0.02 (-1.57%)

CUR

Neuralstem

$0.31

-0.0071 (-2.25%)

NVLS

Nivalis Therapeutics

$2.24

-0.09 (-3.86%)

OMED

OncoMed

$8.68

0.39 (4.70%)

PIRS

Pieris Pharmaceuticals

$1.88

0.12 (6.82%)

RETA

Reata Pharmaceuticals

$23.92

-0.35 (-1.44%)

RARE

Ultragenyx

$76.97

0.6 (0.79%)

STML

Stemline

$12.90

1.55 (13.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

  • 09

    Jan

  • 11

    Jan

  • 01

    Feb

CELG

Celgene

$118.55

-0.2 (-0.17%)

, ALKS

Alkermes

$59.90

3.8 (6.77%)

07:33
01/05/17
01/05
07:33
01/05/17
07:33
Recommendations
Celgene, Alkermes among Jefferies' top 2017 Biotech picks »

Jefferies'…

CELG

Celgene

$118.55

-0.2 (-0.17%)

ALKS

Alkermes

$59.90

3.8 (6.77%)

GILD

Gilead

$76.38

2.22 (2.99%)

VRTX

Vertex

$77.05

2.16 (2.88%)

GNMX

Aevi Genomics Medicine

$5.50

0.06 (1.10%)

ALDR

Alder Biopharmaceuticals

$22.45

1.2 (5.65%)

AMAG

AMAG Pharmaceuticals

$34.65

0.7 (2.06%)

DBVT

DBV Technologies

$34.49

-0.24 (-0.69%)

IMMU

Immunomedics

$3.75

0.02 (0.54%)

RXDX

Ignyta

$5.10

0.1 (2.00%)

KPTI

Karyopharm

$10.56

0.92 (9.54%)

RARX

RA Pharmaceuticals

$15.33

0.14 (0.92%)

TXMD

TherapeuticsMD

$6.42

0.45 (7.54%)

XENE

Xenon Pharmaceuticals

$7.95

0.1 (1.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jan

  • 25

    Jan

  • 26

    Jan

  • 01

    Feb

  • 16

    Feb

  • 24

    Feb

  • 07

    May

  • 08

    Jun

Over a quarter ago
DBVT

DBV Technologies

$35.66

0.99 (2.86%)

05:09
11/08/16
11/08
05:09
11/08/16
05:09
Hot Stocks
DBV Technologies completes enrollment of Phase II study of Viaskin Milk »

DBV Technologies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$34.01

-0.02 (-0.06%)

15:24
11/03/16
11/03
15:24
11/03/16
15:24
Hot Stocks
Meet DBV Technologies: COO says Viaskin had 'favorable' results beyond food »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DBVT

DBV Technologies

$34.01

-0.02 (-0.06%)

15:04
11/03/16
11/03
15:04
11/03/16
15:04
Hot Stocks
Meet DBV Technologies: COO sees competition as beneficial for patients »

In an exclusive interview…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.